Wang, W., Cortes, J. E., Tang, G., Khoury, J. D., Wang, S., Bueso-Ramos, C. E., . . . Hu, S. (2016). Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy. Blood.
Citación estilo ChicagoWang, Wei, et al. "Risk Stratification of Chromosomal Abnormalities in Chronic Myelogenous Leukemia in the Era of Tyrosine Kinase Inhibitor Therapy." Blood 2016.
Cita MLAWang, Wei, et al. "Risk Stratification of Chromosomal Abnormalities in Chronic Myelogenous Leukemia in the Era of Tyrosine Kinase Inhibitor Therapy." Blood 2016.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.